The efficacy and safety of anlotinib for subsequent line treatment of small cell lung cancer: a systematic review and meta-analysis.
Huilin XuDedong CaoFangfang JieAnbing HeWei GePublished in: Tumori (2022)
Anlotinib may be associated with favorable efficacy outcomes in pre-treated SCLC patients with acceptable safety.